Felicity E. Lumb
Glasgow, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Reduction in creatine metabolites in macrophages exposed to small molecule analogues of the anti-inflammatory parasitic worm product ES-62.
Journal: Parasite immunology
Published: November 01, 2023
Protection against lung pathology during obesity-accelerated ageing in mice by the parasitic worm product ES-62.
Journal: Frontiers in immunology
Published: October 02, 2023
Suppression of inflammatory arthritis by the parasitic worm product ES-62 is associated with epigenetic changes in synovial fibroblasts.
Journal: PLoS pathogens
Published: June 21, 2021
Synthetic small molecule analogues of the immunomodulatory Acanthocheilonema viteae product ES-62 promote metabolic homeostasis during obesity in a mouse model.
Journal: Molecular and biochemical parasitology
Published: August 27, 2019
The parasitic worm product ES-62 normalises the gut microbiota bone marrow axis in inflammatory arthritis.
Journal: Nature communications
Published: July 23, 2018
Site-specific glycoproteomic characterization of ES-62: The major secreted product of the parasitic worm Acanthocheilonema viteae.
Journal: Glycobiology
Published: July 20, 2018
Failure of the Anti-Inflammatory Parasitic Worm Product ES-62 to Provide Protection in Mouse Models of Type I Diabetes, Multiple Sclerosis, and Inflammatory Bowel Disease.
Journal: Molecules (Basel, Switzerland)
Published: July 11, 2018
Protection Against Arthritis by the Parasitic Worm Product ES-62, and Its Drug-Like Small Molecule Analogues, Is Associated With Inhibition of Osteoclastogenesis.
Journal: Frontiers in immunology
Published: December 02, 2017
Last Updated: 09/26/2026